Related Experiment Videos
The role of hepatitis B surface antigen in the pathogenesis of glomerulopathies
Insights
Hepatitis B surface antigen (HBsAg) was found in 16.3% of patients with immune complex glomerulonephritis (GN) and nephrotic syndrome. HBsAg-containing immune complexes may contribute to GN and nephrotic syndrome development.
Area of Science:
- Nephrology
- Hepatology
- Immunology
Background:
- Glomerulonephritis (GN) and nephrotic syndrome are significant kidney diseases.
- The role of hepatitis B virus (HBV) in renal pathology is an area of ongoing research.
- Immune complex deposition is a key factor in the pathogenesis of many kidney diseases.
Purpose of the Study:
- To investigate the prevalence of hepatitis B surface antigen (HBsAg) in patients with various kidney diseases.
- To determine if HBsAg is associated with immune complex glomerulonephritis (IC GN) and nephrotic syndrome.
- To explore the potential role of HBsAg-containing immune complexes in the pathogenesis of these renal conditions.
Main Methods:
- Analysis of sera and renal biopsies from 276 patients with GN, nephrotic syndrome, and other nephropathies.
- Detection of HBsAg in sera using a modified Hepanosticon method.
- Detection of HBsAg in renal biopsy tissues using indirect immunofluorescence.
Main Results:
- HBsAg was detected in the sera of 16.3% of patients with IC GN and nephrotic syndrome.
- HBsAg was identified in 16.8% of renal biopsy specimens from these patients.
- A lower prevalence of HBsAg (5%) was observed in patients with other renal diseases compared to controls (0.99% in blood donors).
Conclusions:
- HBsAg-containing immune complexes may play a role in the development and progression of GN and nephrotic syndrome.
- The findings suggest a potential link between HBV infection and specific forms of kidney disease.
- Further research is warranted to elucidate the precise mechanisms of HBsAg involvement in renal pathology.
Abstract:
The frequency of hepatitis B surface antigen (HBsAg) has been studied in the sera and renal biopsies of 276 patients with various forms of glomerulonephritis (GN), the nephrotic syndrome and other nephropathies. Using a modified Hepanosticon method, HBs antigenemia was detected in 32 of 196 patients (16.3%) with immune complex (IC) GN and the nephrotic syndrome. Indirect immunofluorescence revealed HBsAg in 33 renal biopsy tissue specimens (16.8%). HBsAg was found in the sera of four of the 80 remaining patients with other renal diseases (5%), and in the renal biopsy tissues of another four (5%). Antibody against HBsAg could only be demonstrated in the serum of one glomerulonephritic patient. The sera of 18,799 normal blood donors were used as controls; of these 186 (0.99%) had positive tests for HBsAg. It is concluded that, in some patients with GN and the nephrotic syndrome, HBsAg-containing IC may be implicated in the development and/or progression of the disease.